Küresel inovasyon ekosistemi etkinliği olan Nexus 2140, teknoloji destekli tüketim için yeni bir manzaranın ortaklaşa inşa edilmesi amacıyla FEC'den yoğun sponsorluk alıyor

Sequenta

company

About

Sequenta is engaged in the discovery and development of clinical diagnostics based on a platform for understanding immune system status.

  • 51 - 100

Details

Industries
Biotechnology,Health Diagnostics,Medical
Founded date
Jan 1, 2008
Number Of Employee
51 - 100
Operating Status
Active

Sequenta is a venture funded biotech company dedicated to the discovery and development of clinical diagnostics based on a revolutionary new platform for understanding immune system status. A profound revolution in the cost of DNA sequencing has enabled the company to develop brand new approaches to measuring the most variable part of the human genome: the immune cell receptor genes. The incredible diversity created by these genes are at the heart of a large number of conditions critical to human health and disease allowing the company to be in a position to inform a large number of clinical decisions using a single powerful assay.

The company was founded in 2008 by entrepreneurs who previously founded ParaAllele BioScience, a successful startup company sold to Affymetrix in 2005.